DK1078051T3 - Fagvisningsselektionssystem til selektion af korrekt foldede proteiner - Google Patents

Fagvisningsselektionssystem til selektion af korrekt foldede proteiner

Info

Publication number
DK1078051T3
DK1078051T3 DK99922306T DK99922306T DK1078051T3 DK 1078051 T3 DK1078051 T3 DK 1078051T3 DK 99922306 T DK99922306 T DK 99922306T DK 99922306 T DK99922306 T DK 99922306T DK 1078051 T3 DK1078051 T3 DK 1078051T3
Authority
DK
Denmark
Prior art keywords
selection
virus
polypeptide
phage display
properly folded
Prior art date
Application number
DK99922306T
Other languages
English (en)
Inventor
Peter Kristensen
Lutz Riechmann
Jean-Luc Jestin
Gregory Paul Winter
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810228.8A external-priority patent/GB9810228D0/en
Priority claimed from GBGB9810223.9A external-priority patent/GB9810223D0/en
Application filed by Domantis Ltd filed Critical Domantis Ltd
Application granted granted Critical
Publication of DK1078051T3 publication Critical patent/DK1078051T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Air Bags (AREA)
  • Circuits Of Receivers In General (AREA)
  • Vehicle Body Suspensions (AREA)
DK99922306T 1998-05-13 1999-05-13 Fagvisningsselektionssystem til selektion af korrekt foldede proteiner DK1078051T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9810228.8A GB9810228D0 (en) 1998-05-13 1998-05-13 Selection method
GBGB9810223.9A GB9810223D0 (en) 1998-05-13 1998-05-13 Selection system
PCT/GB1999/001526 WO1999058655A2 (en) 1998-05-13 1999-05-13 Phage display selection system for folded proteins

Publications (1)

Publication Number Publication Date
DK1078051T3 true DK1078051T3 (da) 2008-04-07

Family

ID=26313668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99922306T DK1078051T3 (da) 1998-05-13 1999-05-13 Fagvisningsselektionssystem til selektion af korrekt foldede proteiner

Country Status (14)

Country Link
US (2) US7442159B1 (da)
EP (2) EP1078051B1 (da)
JP (2) JP4493846B2 (da)
AT (1) ATE380865T1 (da)
AU (1) AU762814B2 (da)
CA (1) CA2328422A1 (da)
CY (1) CY1107293T1 (da)
DE (1) DE69937735T2 (da)
DK (1) DK1078051T3 (da)
ES (1) ES2299244T3 (da)
GB (1) GB2361237A (da)
NO (1) NO329172B1 (da)
PT (1) PT1078051E (da)
WO (1) WO1999058655A2 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140918A0 (en) 1998-07-27 2002-02-10 Genentech Inc Improved transformation efficiency in phage display through modification of a coat protein
ATE417925T1 (de) 1999-07-20 2009-01-15 Morphosys Ag Verfahren zur präsentation von (poly)peptiden/proteinen auf bakteriophagenpartikeln via disulfidbindungen
JP2003523742A (ja) * 2000-02-03 2003-08-12 ドマンティス リミテッド コンビナトリアルタンパク質ドメイン
GB0019049D0 (en) * 2000-08-04 2000-09-27 Neutec Pharma Plc Combinatorial chemistry method
AU2001277614A1 (en) * 2000-08-07 2002-02-18 Domantis Limited Novel proteins
DE10135039C1 (de) * 2001-07-18 2003-03-13 Nemod Immuntherapie Ag Verfahren zur Isolierung großer Varianzen spezifischer Moleküle für ein Zielmolekül aus Phagemid-Gen-Bibliotheken
EP1627062A1 (en) 2003-05-14 2006-02-22 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
BRPI0613593A2 (pt) * 2005-07-08 2011-01-18 Univ Zuerich método de teste "phage display" filamentoso, vetor de fago ou de fagomìdeo e biblioteca de vetores de fago ou fagomìdeo
GB2428293A (en) * 2005-07-13 2007-01-24 Domantis Ltd Phage display libraries
EP1915617B1 (en) 2005-07-21 2011-09-14 Aebi Ltd. Methods and compositions for identifying a peptide having an intermolecular interaction with a target of interest
GB0515115D0 (en) 2005-07-22 2005-08-31 Isogenica Ltd Peptide characterisation
EP2502628B1 (en) * 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
CA2688433A1 (en) 2007-06-06 2008-12-11 Domantis Limited Methods for selecting protease resistant polypeptides
EP2190987B1 (en) 2007-08-21 2012-11-14 MorphoSys AG Methods for the formation of disulphide bonds
EP2615115A3 (en) 2007-11-30 2014-01-08 Glaxo Group Limited Antigen-binding constructs
MX336869B (es) 2008-11-03 2016-02-04 Alethia Biotherapeutics Inc Anticuerpos que bloquean espicificamente la actividad biologica de un antigeno de tumor.
SG194383A1 (en) 2008-12-05 2013-11-29 Glaxo Group Ltd Methods for selecting protease resistant polypeptides
EP2401297A1 (en) 2009-02-24 2012-01-04 Glaxo Group Limited Antigen-binding constructs
EP2401298A1 (en) 2009-02-24 2012-01-04 Glaxo Group Limited Antigen-binding constructs
WO2010097394A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Multivalent and/or multispecific rankl-binding constructs
KR20130121886A (ko) 2010-11-24 2013-11-06 글락소 그룹 리미티드 Ｈｇｆ를 표적으로 하는 다중특이적 항원 결합 단백질
KR101993259B1 (ko) 2011-03-31 2019-06-27 에이디씨 테라퓨틱스 에스에이 신장 결합 항원 １에 대한 항체 및 이의 항원 결합 단편
US9499612B2 (en) 2011-07-27 2016-11-22 Glaxo Group Limited Antigen binding constructs
AU2012327806B2 (en) * 2011-10-27 2018-07-19 The Governors Of The University Of Alberta Device and method for bacterial culture and assay
DK2802351T3 (da) 2012-01-09 2019-05-13 Adc Therapeutics Sa Midler til behandling af triple-negativ brystkræft
KR20230011497A (ko) 2013-09-25 2023-01-20 싸이톰스 테라퓨틱스, 인크. 매트릭스 메탈로프로테이나제 기질 및 다른 절단성 모이어티 및 이의 사용 방법
CN114106099B (zh) 2014-01-31 2024-05-24 西托姆克斯治疗公司 蛋白裂解酶和u型纤溶酶原激活物的底物和其它可裂解部分及其使用方法
WO2016074683A1 (en) * 2014-11-11 2016-05-19 Lundorf Pedersen Materials Aps Method for identification of molecules with desired characteristics
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
EP3277317A1 (en) * 2015-03-31 2018-02-07 VHsquared Limited Peptide construct having a protease-cleavable linker
WO2020254644A1 (en) * 2019-06-21 2020-12-24 Boehringer Ingelheim International Gmbh Novel mechanism to control rna virus replication and gene expression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO1990005144A1 (en) 1988-11-11 1990-05-17 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0585287T3 (da) * 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
JP4146512B2 (ja) * 1991-03-01 2008-09-10 ダイアックス コープ． 小型タンパク質
DE4122599C2 (de) * 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
WO1993011236A1 (en) 1991-12-02 1993-06-10 Medical Research Council Production of anti-self antibodies from antibody segment repertoires and displayed on phage

Also Published As

Publication number Publication date
WO1999058655A3 (en) 2000-01-27
US7442159B1 (en) 2008-10-28
DE69937735T2 (de) 2008-11-27
CA2328422A1 (en) 1999-11-18
AU3941399A (en) 1999-11-29
JP5161865B2 (ja) 2013-03-13
WO1999058655A2 (en) 1999-11-18
EP1078051B1 (en) 2007-12-12
ES2299244T3 (es) 2008-05-16
US8680018B2 (en) 2014-03-25
CY1107293T1 (el) 2012-11-21
EP1078051A2 (en) 2001-02-28
JP2002514413A (ja) 2002-05-21
AU762814B2 (en) 2003-07-03
NO20005628D0 (no) 2000-11-08
PT1078051E (pt) 2008-03-17
JP2010148507A (ja) 2010-07-08
NO20005628L (no) 2001-01-12
NO329172B1 (no) 2010-09-06
US20090203542A1 (en) 2009-08-13
GB0026143D0 (en) 2000-12-13
JP4493846B2 (ja) 2010-06-30
EP1950295A1 (en) 2008-07-30
GB2361237A (en) 2001-10-17
ATE380865T1 (de) 2007-12-15
DE69937735D1 (de) 2008-01-24

Similar Documents

Publication Publication Date Title
DK1078051T3 (da) Fagvisningsselektionssystem til selektion af korrekt foldede proteiner
DK0816506T3 (da) System til ekspression af heterologe antigener som fusionsproteiner
DK1065271T3 (da) Fagmid til screening af antistoffer
HK1036475A1 (en) Erythropoietin analog-human serum albumin fusion protein
BR9810654B1 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
AR009436A1 (es) UNA PROTEíNA DE FUSIoN FC-OB, UNA SECUENCIA DE ÁCIDO NUCLEICO QUE LA CODIFICA, UN VECTOR, PROCEDIMIENTO DE PREPARACIoN, COMPOSICIONES FARMACÉUTICAS Y USOS.
DK0977873T3 (da) Fremgangsmåde til spaltning af fusionsproteiner
DE69633563D1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
AU2002235884A1 (en) Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
DE69531235D1 (de) Säugetier - Expressionssysteme für Hüllenprotingene des Hepatitit - C - Virus
IS6678A (is) Hvarfefni og prófanir fyrir ß-sekretasavirkni
NO20052552D0 (no) Loselige Notch-baserte substrater for gamma-sekretase og fremgangsmater og blandinger for anvendelse av samme.
WO2000031127A3 (en) Protein fragments for use in protein targeting
DE69611896D1 (de) Fusions-DNS-Sequenz, dadurch exprimiertes Fusionsprotein und Verfahren zur Expression dieses Fusionsproteins
ATE294237T1 (de) S?ugetier thymokingene
IS5174A (is) Aðferð til framleiðslu á O-(3-amínó-2-hýdroxý-própýl)-hýdroxýmsýru halíð
DK0401657T3 (da) Fremgangsmåde til C-terminal modificering af proteiner
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
WO1997039020A3 (en) Antigenic sequences of a sperm protein and immunocontraceptive methods
DE59105878D1 (de) VERFAHREN ZUR ENZYMATISCHEN SPALTUNG REKOMBINANTER PROTEINE UNTER VERWENDUNG VON IgA-PROTEASEN.